Report Detail
Global Inosine Pranobex Market Growth 2019-2024
- RnM3072390 |
- 07 March, 2019 |
- Global |
- 163 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.
The classification of Inosine Pranobex includes Tablet, Syrup, the sales of Tablet are 8.45 million units, with its market share 69.3%. And the sales market share of Syrup is 30.7% in 2017.
Inosine Pranobex is widely used to treat Immunomodulation, Antiviral and Other. The most proportion of Inosine Pranobex is to treat Antiviral, and the proportion is about 48.6% in 2017.
Europe region is the largest supplier of Inosine Pranobex, with a production market share nearly 57% in 2017. North America is the second largest supplier of Inosine Pranobex, enjoying revenue market share nearly 8.7% in 2017.
According to this study, over the next five years the Inosine Pranobex market will register a 1.9% CAGR in terms of revenue, the global market size will reach US$ 210 million by 2024, from US$ 180 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Inosine Pranobex business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Inosine Pranobex market by product type, application, key manufacturers and key regions and countries.
This study considers the Inosine Pranobex value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Tablet
Syrup
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Immunomodulation
Antiviral
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Newport Pharmaceuticals
Gedeon Richter
Mochida
Sanofi
Andrómaco
Yung Shin
Sigma -Tau
Polfarmex
Sanfer
Meprofarm
Novell Pharmaceutical
Aflofarm
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Inosine Pranobex consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Inosine Pranobex market by identifying its various subsegments.
Focuses on the key global Inosine Pranobex manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Inosine Pranobex with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Inosine Pranobex submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Inosine Pranobex Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Inosine Pranobex Consumption 2014-2024
- 2.1.2 Inosine Pranobex Consumption CAGR by Region
- 2.2 Inosine Pranobex Segment by Type
- 2.2.1 Tablet
- 2.2.2 Syrup
- 2.3 Inosine Pranobex Consumption by Type
- 2.3.1 Global Inosine Pranobex Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Inosine Pranobex Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Inosine Pranobex Sale Price by Type (2014-2019)
- 2.4 Inosine Pranobex Segment by Application
- 2.4.1 Immunomodulation
- 2.4.2 Antiviral
- 2.4.3 Other
- 2.5 Inosine Pranobex Consumption by Application
- 2.5.1 Global Inosine Pranobex Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Inosine Pranobex Value and Market Share by Application (2014-2019)
- 2.5.3 Global Inosine Pranobex Sale Price by Application (2014-2019)
3 Global Inosine Pranobex by Players
- 3.1 Global Inosine Pranobex Sales Market Share by Players
- 3.1.1 Global Inosine Pranobex Sales by Players (2017-2019)
- 3.1.2 Global Inosine Pranobex Sales Market Share by Players (2017-2019)
- 3.2 Global Inosine Pranobex Revenue Market Share by Players
- 3.2.1 Global Inosine Pranobex Revenue by Players (2017-2019)
- 3.2.2 Global Inosine Pranobex Revenue Market Share by Players (2017-2019)
- 3.3 Global Inosine Pranobex Sale Price by Players
- 3.4 Global Inosine Pranobex Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Inosine Pranobex Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Inosine Pranobex Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Inosine Pranobex by Regions
- 4.1 Inosine Pranobex by Regions
- 4.1.1 Global Inosine Pranobex Consumption by Regions
- 4.1.2 Global Inosine Pranobex Value by Regions
- 4.2 Americas Inosine Pranobex Consumption Growth
- 4.3 APAC Inosine Pranobex Consumption Growth
- 4.4 Europe Inosine Pranobex Consumption Growth
- 4.5 Middle East & Africa Inosine Pranobex Consumption Growth
5 Americas
- 5.1 Americas Inosine Pranobex Consumption by Countries
- 5.1.1 Americas Inosine Pranobex Consumption by Countries (2014-2019)
- 5.1.2 Americas Inosine Pranobex Value by Countries (2014-2019)
- 5.2 Americas Inosine Pranobex Consumption by Type
- 5.3 Americas Inosine Pranobex Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Inosine Pranobex Consumption by Countries
- 6.1.1 APAC Inosine Pranobex Consumption by Countries (2014-2019)
- 6.1.2 APAC Inosine Pranobex Value by Countries (2014-2019)
- 6.2 APAC Inosine Pranobex Consumption by Type
- 6.3 APAC Inosine Pranobex Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Inosine Pranobex by Countries
- 7.1.1 Europe Inosine Pranobex Consumption by Countries (2014-2019)
- 7.1.2 Europe Inosine Pranobex Value by Countries (2014-2019)
- 7.2 Europe Inosine Pranobex Consumption by Type
- 7.3 Europe Inosine Pranobex Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Inosine Pranobex by Countries
- 8.1.1 Middle East & Africa Inosine Pranobex Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Inosine Pranobex Value by Countries (2014-2019)
- 8.2 Middle East & Africa Inosine Pranobex Consumption by Type
- 8.3 Middle East & Africa Inosine Pranobex Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Inosine Pranobex Distributors
- 10.3 Inosine Pranobex Customer
11 Global Inosine Pranobex Market Forecast
- 11.1 Global Inosine Pranobex Consumption Forecast (2019-2024)
- 11.2 Global Inosine Pranobex Forecast by Regions
- 11.2.1 Global Inosine Pranobex Forecast by Regions (2019-2024)
- 11.2.2 Global Inosine Pranobex Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Inosine Pranobex Forecast by Type
- 11.8 Global Inosine Pranobex Forecast by Application
12 Key Players Analysis
- 12.1 Newport Pharmaceuticals
- 12.1.1 Company Details
- 12.1.2 Inosine Pranobex Product Offered
- 12.1.3 Newport Pharmaceuticals Inosine Pranobex Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Newport Pharmaceuticals News
- 12.2 Gedeon Richter
- 12.2.1 Company Details
- 12.2.2 Inosine Pranobex Product Offered
- 12.2.3 Gedeon Richter Inosine Pranobex Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Gedeon Richter News
- 12.3 Mochida
- 12.3.1 Company Details
- 12.3.2 Inosine Pranobex Product Offered
- 12.3.3 Mochida Inosine Pranobex Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Mochida News
- 12.4 Sanofi
- 12.4.1 Company Details
- 12.4.2 Inosine Pranobex Product Offered
- 12.4.3 Sanofi Inosine Pranobex Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Sanofi News
- 12.5 Andrómaco
- 12.5.1 Company Details
- 12.5.2 Inosine Pranobex Product Offered
- 12.5.3 Andrómaco Inosine Pranobex Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Andrómaco News
- 12.6 Yung Shin
- 12.6.1 Company Details
- 12.6.2 Inosine Pranobex Product Offered
- 12.6.3 Yung Shin Inosine Pranobex Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Yung Shin News
- 12.7 Sigma -Tau
- 12.7.1 Company Details
- 12.7.2 Inosine Pranobex Product Offered
- 12.7.3 Sigma -Tau Inosine Pranobex Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Sigma -Tau News
- 12.8 Polfarmex
- 12.8.1 Company Details
- 12.8.2 Inosine Pranobex Product Offered
- 12.8.3 Polfarmex Inosine Pranobex Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Polfarmex News
- 12.9 Sanfer
- 12.9.1 Company Details
- 12.9.2 Inosine Pranobex Product Offered
- 12.9.3 Sanfer Inosine Pranobex Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Sanfer News
- 12.10 Meprofarm
- 12.10.1 Company Details
- 12.10.2 Inosine Pranobex Product Offered
- 12.10.3 Meprofarm Inosine Pranobex Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Meprofarm News
- 12.11 Novell Pharmaceutical
- 12.12 Aflofarm
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Inosine Pranobex. Industry analysis & Market Report on Inosine Pranobex is a syndicated market report, published as Global Inosine Pranobex Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Inosine Pranobex market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
